Patent Assignment
Reel/Frame 042659/0741
Assignment of Assignor's Interest
Recorded: 2017-06-09
Pages: 16
Assignor
SANTARUS, INC.
Executed: 2017-05-23
Assignee
PHARMING AMERICAS B.V.
DARWINWEG 24, LEIDEN, 2333 CR, NETHERLANDS
Covered Properties
(2)
Treatment of Hereditary Angioedema with C1 Inhibitor
Application:
15/122,130 →
Publication:
US 2016/0361394
Treatment of Hereditary Angioedema with C1 Inhibitor
Application:
61/946,677 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Apr 2, 2015
From: GLYCYX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 035364/0396 →
Security Interest
Dec 7, 2016
From: PHARMING AMERICAS B.V.
To: SILICON VALLEY BANK
Reel/Frame 040593/0914 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING AMERICAS B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0174 →
Assignment of Assignor's Interest
Jun 9, 2017
From: TOTORITIS, MARK C.
To: SANTARUS, INC.
Reel/Frame 042659/0674 →
Release of Security Interest
Jan 28, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: PHARMING GROUP N.V.; PHARMING TECHNOLOGIES B.V.; PHARMING INTELLECTUAL PROPERTY B.V.; BROEKMAN INSTITUUT B.V.
Reel/Frame 051722/0304 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →